Net income decreased 80.0%
Net income changed -80.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed -80.0% from the comparable as-filed period.
Operating income changed -33.6% from the comparable as-filed period.
Research & development changed +10.8% from the comparable as-filed period.
Cash & equivalents changed +19.2% from the comparable as-filed period.
Gross margin changed -253 basis points from the comparable as-filed period.
Operating margin changed -263 basis points from the comparable as-filed period.
Revenue changed +7.4% from the comparable as-filed period.
Selling, general & administrative changed +8.7% from the comparable as-filed period.
Gross profit changed -5.5% from the comparable as-filed period.
Debt changed +4.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed -3.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.